GSK names Luke Miels as next CEO
Miels will formally assume the role on January 1, 2026
Miels will formally assume the role on January 1, 2026
The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply British-made COVID-19 vaccines to the UK population
The TULIP-SC trial investigated the efficacy and safety of subcutaneous Saphnelo
RTX001 represents a groundbreaking advance in the treatment of end-stage liver disease, offering new hope for patients with limited options
This case report is jointly authored by US clinicians from leading hospitals, Houston Methodist Hospital, Weill Cornell Medical College and Johns Hopkins
The system is powered by advanced imaging innovations such as Amber-red Color Imaging, Triple Noise Reduction, and Extended Dynamic Range Image Processing
Carson brings with him over two decades of experience in Communications, Public Affairs, and Sustainability
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
Launches collaborative centre for translational research in head and neck cancer
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
Subscribe To Our Newsletter & Stay Updated